Global Renal Biomarkers Market Size study & Forecast, by Biomarker type (Functional Biomarker, Up-regulated Protein, and Other Biomarker Types) by Diagnostic Technique ((Enzyme-linked Immunosorbent Assay, Particle-enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), and Liquid Chromatography-mass Spectrometry (LS-MS)), by End User (Hospitals, Diagnostic Laboratories, and Other End Users) and Regional Analysis, 2022-2029
Global Renal Biomarkers Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. A biomarker is a biological characteristic of an organism that is assessed as a sign of typical biological function. Renal biomarkers are a crucial diagnostic tool for identifying both acute and chronic kidney injury as well as several other kidney disorders. Renal disorders are primarily treated using renal biomarkers. These biomarkers are helpful in both research and clinical contexts and are used to analyze the renal system's functionality. The Renal Biomarkers Market is expanding because of factors such as the increasing incidence of various kidney-related diseases, and the increasing rate of progression of chronic kidney disease.
A Kidney International Supplements article from April 2022 claims that millions of people worldwide pass away each year from chronic kidney disease, which affects about 10% of the world's population. Chronic renal disease individuals are becoming more prevalent. Also, compared to Western nations, Asian nations had a significantly higher incidence of diabetes-related chronic renal illnesses. For instance, according to a 2021 report from the International Diabetes Federation, India had an estimated 74,194.7 thousand cases of diabetes in 2021, and by 2030, that number is predicted to rise to 92,973.7 thousand cases. Thus, it is anticipated that over the projection period, demand for renal disease diagnosis would rise in response to the rising prevalence of kidney illnesses and their associated causes. This will fuel the development of biomarkers. Furthermore, advancements in the field of genetic technology strategic activities by market players for product development are creating lucrative growth in the market. However, the high cost of renal biomarkers may halt market growth.
The key regions considered for the Global Renal Biomarkers Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Abbott Laboratories
BioPorto Diagnostics AS
F. Hoffmann-La Roche AG
Thermo Fisher Scientific Inc.
Nexelis (Pacific Biomarkers)
BioMйrieux
Sphingotec GmbH
Randox Laboratories Ltd
Siemens Healthineers AG
Enzo Life Sciences, Inc.
Recent Developments in the Market:
In December 2022, the company Journey Biosciences, Inc. has announced the release of NaviDKD, its flagship product, a blood test based on biomarkers that forecast long-term kidney issues in diabetics. The only screening method that gives diabetics a head starts on the risk of developing kidney disease.
In March 2022, Renalytix plc has announced the launch of myIntelX, a new provider access portal that will enable doctors to order KidneyIntelX prognostic (blood-based biomarker) testing online for more accurate identification of patients at the highest risk of rapid progression of kidney disease in type 2 diabetes.
Global Renal Biomarkers Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Biomarker type, Diagnostic Technique, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Biomarker typeofferings of key players. The detailed segments and sub-segment of the market are explained below:
By Biomarker Type:
Functional Biomarker
Up-regulated Protein
Other Biomarker Types
By Diagnostic Technique:
Enzyme-linked Immunosorbent Assay
Particle-enhanced Turbidimetric Immunoassay (PETIA)
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay (CLIA)
Liquid Chromatography-mass Spectrometry (LS-MS)
By End User:
Hospitals
Diagnostic Laboratories
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
A Kidney International Supplements article from April 2022 claims that millions of people worldwide pass away each year from chronic kidney disease, which affects about 10% of the world's population. Chronic renal disease individuals are becoming more prevalent. Also, compared to Western nations, Asian nations had a significantly higher incidence of diabetes-related chronic renal illnesses. For instance, according to a 2021 report from the International Diabetes Federation, India had an estimated 74,194.7 thousand cases of diabetes in 2021, and by 2030, that number is predicted to rise to 92,973.7 thousand cases. Thus, it is anticipated that over the projection period, demand for renal disease diagnosis would rise in response to the rising prevalence of kidney illnesses and their associated causes. This will fuel the development of biomarkers. Furthermore, advancements in the field of genetic technology strategic activities by market players for product development are creating lucrative growth in the market. However, the high cost of renal biomarkers may halt market growth.
The key regions considered for the Global Renal Biomarkers Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Abbott Laboratories
BioPorto Diagnostics AS
F. Hoffmann-La Roche AG
Thermo Fisher Scientific Inc.
Nexelis (Pacific Biomarkers)
BioMйrieux
Sphingotec GmbH
Randox Laboratories Ltd
Siemens Healthineers AG
Enzo Life Sciences, Inc.
Recent Developments in the Market:
In December 2022, the company Journey Biosciences, Inc. has announced the release of NaviDKD, its flagship product, a blood test based on biomarkers that forecast long-term kidney issues in diabetics. The only screening method that gives diabetics a head starts on the risk of developing kidney disease.
In March 2022, Renalytix plc has announced the launch of myIntelX, a new provider access portal that will enable doctors to order KidneyIntelX prognostic (blood-based biomarker) testing online for more accurate identification of patients at the highest risk of rapid progression of kidney disease in type 2 diabetes.
Global Renal Biomarkers Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Biomarker type, Diagnostic Technique, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Biomarker typeofferings of key players. The detailed segments and sub-segment of the market are explained below:
By Biomarker Type:
Functional Biomarker
Up-regulated Protein
Other Biomarker Types
By Diagnostic Technique:
Enzyme-linked Immunosorbent Assay
Particle-enhanced Turbidimetric Immunoassay (PETIA)
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay (CLIA)
Liquid Chromatography-mass Spectrometry (LS-MS)
By End User:
Hospitals
Diagnostic Laboratories
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Renal Biomarkers Market, by Region, 2019-2029 (USD Billion)
1.2.2. Renal Biomarkers Market, by Biomarker Type, 2019-2029 (USD Billion)
1.2.3. Renal Biomarkers Market, by Diagnostic Technique, 2019-2029 (USD Billion)
1.2.4. Renal Biomarkers Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL RENAL BIOMARKERS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL RENAL BIOMARKERS MARKET DYNAMICS
3.1. Renal Biomarkers Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of various kidney-related diseases,
3.1.1.2. increasing rate of progression of chronic kidney disease
3.1.2. Market Challenges
3.1.2.1. High Cost of Renal Biomarkers
3.1.3. Market Opportunities
3.1.3.1. Advancements in the field of genetic technology
3.1.3.2. Strategic activities by market players for product development
CHAPTER 4. GLOBAL RENAL BIOMARKERS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL RENAL BIOMARKERS MARKET, BY BIOMARKER TYPE
6.1. Market Snapshot
6.2. Global Renal Biomarkers Market by Biomarker Type, Performance - Potential Analysis
6.3. Global Renal Biomarkers Market Estimates & Forecasts by Biomarker Type 2019-2029 (USD Billion)
6.4. Renal Biomarkers Market, Sub Segment Analysis
6.4.1. Functional Biomarker
6.4.2. Up-regulated Protein
6.4.3. Other Biomarker Types
CHAPTER 7. GLOBAL RENAL BIOMARKERS MARKET, BY DIAGNOSTIC TECHNIQUE
7.1. Market Snapshot
7.2. Global Renal Biomarkers Market by Diagnostic Technique, Performance - Potential Analysis
7.3. Global Renal Biomarkers Market Estimates & Forecasts by Diagnostic Technique 2019-2029 (USD Billion)
7.4. Renal Biomarkers Market, Sub Segment Analysis
7.4.1. Enzyme-linked Immunosorbent Assay
7.4.2. Particle-enhanced Turbidimetric Immunoassay (PETIA)
7.4.3. Colorimetric Assay
7.4.4. Chemiluminescent Enzyme Immunoassay (CLIA)
7.4.5. Liquid Chromatography-mass Spectrometry (LS-MS)
CHAPTER 8. GLOBAL RENAL BIOMARKERS MARKET, BY END USER
8.1. Market Snapshot
8.2. Global Renal Biomarkers Market by End User, Performance - Potential Analysis
8.3. Global Renal Biomarkers Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
8.4. Renal Biomarkers Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Diagnostic Laboratories
8.4.3. Other End Users
CHAPTER 9. GLOBAL RENAL BIOMARKERS MARKET, REGIONAL ANALYSIS
9.1. Renal Biomarkers Market, Regional Market Snapshot
9.2. North America Renal Biomarkers Market
9.2.1. U.S. Renal Biomarkers Market
9.2.1.1. Biomarker Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Diagnostic Technique breakdown estimates & forecasts, 2019-2029
9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Renal Biomarkers Market
9.3. Europe Renal Biomarkers Market Snapshot
9.3.1. U.K. Renal Biomarkers Market
9.3.2. Germany Renal Biomarkers Market
9.3.3. France Renal Biomarkers Market
9.3.4. Spain Renal Biomarkers Market
9.3.5. Italy Renal Biomarkers Market
9.3.6. Rest of Europe Renal Biomarkers Market
9.4. Asia-Pacific Renal Biomarkers Market Snapshot
9.4.1. China Renal Biomarkers Market
9.4.2. India Renal Biomarkers Market
9.4.3. Japan Renal Biomarkers Market
9.4.4. Australia Renal Biomarkers Market
9.4.5. South Korea Renal Biomarkers Market
9.4.6. Rest of Asia Pacific Renal Biomarkers Market
9.5. Latin America Renal Biomarkers Market Snapshot
9.5.1. Brazil Renal Biomarkers Market
9.5.2. Mexico Renal Biomarkers Market
9.5.3. Rest of Latin America Renal Biomarkers Market
9.6. Rest of The World Renal Biomarkers Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Abbott Laboratories
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. BioPorto Diagnostics AS
10.2.3. F. Hoffmann-La Roche AG
10.2.4. Thermo Fisher Scientific Inc.
10.2.5. Nexelis (Pacific Biomarkers)
10.2.6. BioMйrieux
10.2.7. Sphingotec GmbH
10.2.8. Randox Laboratories Ltd
10.2.9. Siemens Healthineers AG
10.2.10. Enzo Life Sciences, Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Renal Biomarkers Market, by Region, 2019-2029 (USD Billion)
1.2.2. Renal Biomarkers Market, by Biomarker Type, 2019-2029 (USD Billion)
1.2.3. Renal Biomarkers Market, by Diagnostic Technique, 2019-2029 (USD Billion)
1.2.4. Renal Biomarkers Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL RENAL BIOMARKERS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL RENAL BIOMARKERS MARKET DYNAMICS
3.1. Renal Biomarkers Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of various kidney-related diseases,
3.1.1.2. increasing rate of progression of chronic kidney disease
3.1.2. Market Challenges
3.1.2.1. High Cost of Renal Biomarkers
3.1.3. Market Opportunities
3.1.3.1. Advancements in the field of genetic technology
3.1.3.2. Strategic activities by market players for product development
CHAPTER 4. GLOBAL RENAL BIOMARKERS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL RENAL BIOMARKERS MARKET, BY BIOMARKER TYPE
6.1. Market Snapshot
6.2. Global Renal Biomarkers Market by Biomarker Type, Performance - Potential Analysis
6.3. Global Renal Biomarkers Market Estimates & Forecasts by Biomarker Type 2019-2029 (USD Billion)
6.4. Renal Biomarkers Market, Sub Segment Analysis
6.4.1. Functional Biomarker
6.4.2. Up-regulated Protein
6.4.3. Other Biomarker Types
CHAPTER 7. GLOBAL RENAL BIOMARKERS MARKET, BY DIAGNOSTIC TECHNIQUE
7.1. Market Snapshot
7.2. Global Renal Biomarkers Market by Diagnostic Technique, Performance - Potential Analysis
7.3. Global Renal Biomarkers Market Estimates & Forecasts by Diagnostic Technique 2019-2029 (USD Billion)
7.4. Renal Biomarkers Market, Sub Segment Analysis
7.4.1. Enzyme-linked Immunosorbent Assay
7.4.2. Particle-enhanced Turbidimetric Immunoassay (PETIA)
7.4.3. Colorimetric Assay
7.4.4. Chemiluminescent Enzyme Immunoassay (CLIA)
7.4.5. Liquid Chromatography-mass Spectrometry (LS-MS)
CHAPTER 8. GLOBAL RENAL BIOMARKERS MARKET, BY END USER
8.1. Market Snapshot
8.2. Global Renal Biomarkers Market by End User, Performance - Potential Analysis
8.3. Global Renal Biomarkers Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
8.4. Renal Biomarkers Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Diagnostic Laboratories
8.4.3. Other End Users
CHAPTER 9. GLOBAL RENAL BIOMARKERS MARKET, REGIONAL ANALYSIS
9.1. Renal Biomarkers Market, Regional Market Snapshot
9.2. North America Renal Biomarkers Market
9.2.1. U.S. Renal Biomarkers Market
9.2.1.1. Biomarker Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Diagnostic Technique breakdown estimates & forecasts, 2019-2029
9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Renal Biomarkers Market
9.3. Europe Renal Biomarkers Market Snapshot
9.3.1. U.K. Renal Biomarkers Market
9.3.2. Germany Renal Biomarkers Market
9.3.3. France Renal Biomarkers Market
9.3.4. Spain Renal Biomarkers Market
9.3.5. Italy Renal Biomarkers Market
9.3.6. Rest of Europe Renal Biomarkers Market
9.4. Asia-Pacific Renal Biomarkers Market Snapshot
9.4.1. China Renal Biomarkers Market
9.4.2. India Renal Biomarkers Market
9.4.3. Japan Renal Biomarkers Market
9.4.4. Australia Renal Biomarkers Market
9.4.5. South Korea Renal Biomarkers Market
9.4.6. Rest of Asia Pacific Renal Biomarkers Market
9.5. Latin America Renal Biomarkers Market Snapshot
9.5.1. Brazil Renal Biomarkers Market
9.5.2. Mexico Renal Biomarkers Market
9.5.3. Rest of Latin America Renal Biomarkers Market
9.6. Rest of The World Renal Biomarkers Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Abbott Laboratories
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. BioPorto Diagnostics AS
10.2.3. F. Hoffmann-La Roche AG
10.2.4. Thermo Fisher Scientific Inc.
10.2.5. Nexelis (Pacific Biomarkers)
10.2.6. BioMйrieux
10.2.7. Sphingotec GmbH
10.2.8. Randox Laboratories Ltd
10.2.9. Siemens Healthineers AG
10.2.10. Enzo Life Sciences, Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Renal Biomarkers Market, report scope
TABLE 2. Global Renal Biomarkers Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Renal Biomarkers Market estimates & forecasts by Biomarker Type 2019-2029 (USD Billion)
TABLE 4. Global Renal Biomarkers Market estimates & forecasts by Diagnostic Technique 2019-2029 (USD Billion)
TABLE 5. Global Renal Biomarkers Market estimates & forecasts by End User 2019-2029 (USD Billion)
TABLE 6. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Renal Biomarkers Market
TABLE 71. List of primary sources, used in the study of global Renal Biomarkers Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Renal Biomarkers Market, report scope
TABLE 2. Global Renal Biomarkers Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Renal Biomarkers Market estimates & forecasts by Biomarker Type 2019-2029 (USD Billion)
TABLE 4. Global Renal Biomarkers Market estimates & forecasts by Diagnostic Technique 2019-2029 (USD Billion)
TABLE 5. Global Renal Biomarkers Market estimates & forecasts by End User 2019-2029 (USD Billion)
TABLE 6. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Renal Biomarkers Market
TABLE 71. List of primary sources, used in the study of global Renal Biomarkers Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Renal Biomarkers Market, research methodology
FIG 2. Global Renal Biomarkers Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Renal Biomarkers Market, key trends 2021
FIG 5. Global Renal Biomarkers Market, growth prospects 2022-2029
FIG 6. Global Renal Biomarkers Market, porters 5 force model
FIG 7. Global Renal Biomarkers Market, pest analysis
FIG 8. Global Renal Biomarkers Market, value chain analysis
FIG 9. Global Renal Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Renal Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Renal Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Renal Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Renal Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Renal Biomarkers Market, regional snapshot 2019 & 2029
FIG 15. North America Renal Biomarkers Market 2019 & 2029 (USD Billion)
FIG 16. Europe Renal Biomarkers Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Renal Biomarkers Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Renal Biomarkers Market 2019 & 2029 (USD Billion)
FIG 19. Global Renal Biomarkers Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Renal Biomarkers Market, research methodology
FIG 2. Global Renal Biomarkers Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Renal Biomarkers Market, key trends 2021
FIG 5. Global Renal Biomarkers Market, growth prospects 2022-2029
FIG 6. Global Renal Biomarkers Market, porters 5 force model
FIG 7. Global Renal Biomarkers Market, pest analysis
FIG 8. Global Renal Biomarkers Market, value chain analysis
FIG 9. Global Renal Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Renal Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Renal Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Renal Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Renal Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Renal Biomarkers Market, regional snapshot 2019 & 2029
FIG 15. North America Renal Biomarkers Market 2019 & 2029 (USD Billion)
FIG 16. Europe Renal Biomarkers Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Renal Biomarkers Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Renal Biomarkers Market 2019 & 2029 (USD Billion)
FIG 19. Global Renal Biomarkers Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
